3 weeks ago

Andhra Health Secretary Urges Zero Tolerance for Poor-Quality Medicines

Andhra Health Secretary Urges Zero Tolerance for Poor-Quality Medicines
Zero Tolerance For Poor-Quality Medicines: Health Secretary · deccanchronicle.com

In Vijayawada, a city in India, important people who watch over medicines held a big meeting.

They wanted to talk about making sure medicines are safe and good.

The top health leader of Andhra Pradesh said the state will not accept medicines of poor quality.

He said medicines made in Andhra Pradesh are used by sick people in many countries.

So keeping them safe helps people everywhere.

Experts from India and the United States shared ideas at the meeting.

They talked about checking medicine factories and testing products carefully.

They also discussed new rules that medicine makers must follow.

Everyone agreed that working together keeps patients safe and healthy.

Key facts

Event
One-day regulatory workshop 'Ensuring Drug Quality: Scientific Approach in Regulations, Standards and Inspections'
Location
Vijayawada, Andhra Pradesh, India
Organizers
AP Drugs Control Administration, US Pharmacopeia (USP), AIDCOC and US FDA India Office
Key speaker
G. Veerapandian, Andhra Pradesh health secretary
Theme
Zero tolerance for poor-quality medicines; science-based regulation
Attendance
More than 75 drug inspectors, government analysts, regulators, industry representatives and technical experts
Topics discussed
Revised Schedule M norms, scientific inspection methods, evidence-based regulatory decision-making

Quotes

G. Veerapandian

Andhra Pradesh Health Secretary

“Regulation should enable quality, innovation and public confidence. Our responsibility extends beyond state and national boundaries because medicines manufactured in Andhra Pradesh serve patients across the world.”
deccanchronicle.com
“Medicine quality is fundamental to patient trust and emphasised that collaboration among regulators, scientists and industry experts would strengthen science‑based regulation and patient safety.”
deccanchronicle.com

Gregory Smith

US FDA India Office Country Director

“Every inspection, laboratory result and regulatory decision ultimately affects patients and stressed the importance of scientific collaboration and sharing best practices to strengthen global regulatory systems.”
deccanchronicle.com

Sources

Related news